Swasti Vinayaka Synthetics Limited carries a market capitalization of 331.20M, placing it among publicly traded companies globally. Its enterprise value stands at 319.69M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 331.20M |
| Enterprise Value | 319.69M |
Swasti Vinayaka Synthetics Limited currently has 90.00M shares outstanding.
| Shares Outstanding | 90.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Swasti Vinayaka Synthetics Limited trades at a trailing price-to-earnings ratio of 9.16. The price-to-sales ratio is 0.87, and the price-to-book ratio stands at 3.10.
| PE Ratio | 9.16 |
| PS Ratio | 0.87 |
| PB Ratio | 3.10 |
| P/TBV Ratio | 1.07 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Swasti Vinayaka Synthetics Limited trades at an EV/EBITDA multiple of 10.32 and an EV/FCF ratio of 46.01. The EV/Sales ratio of 1.00 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.32 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.00 |
| EV / EBITDA | 10.32 |
| EV / EBIT | 10.32 |
| EV / FCF | 46.01 |
Swasti Vinayaka Synthetics Limited maintains a current ratio of 5.01, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.28, indicating elevated leverage, while an interest coverage ratio of 3.38 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 5.01 |
| Quick Ratio | 0.04 |
| Debt / Equity | 16.28 |
| Debt / EBITDA | 1.37 |
| Interest Coverage | 3.38 |
Swasti Vinayaka Synthetics Limited posts a return on equity of 21.61 and a return on invested capital of 6.98.
| Return on Equity (ROE) | 21.61 |
| Return on Assets (ROA) | 7.11 |
| Return on Invested Capital (ROIC) | 6.98 |
| Return on Capital Employed (ROCE) | 19.45 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.04 |
Over the trailing twelve months, Swasti Vinayaka Synthetics Limited has paid 9.77M in income taxes, reflecting an effective tax rate of 24.26.
| Income Tax | 9.77M |
| Effective Tax Rate | 24.26 |
Swasti Vinayaka Synthetics Limited's stock has declined approximately -34.98233% over the past 52 weeks. The 50-day moving average sits at 3.96, while the 200-day moving average is 4.17.
| Beta (5Y) | N/A |
| 52-Week Price Change | -34.98233% |
| 50-Day Moving Average | 3.96 |
| 200-Day Moving Average | 4.17 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Swasti Vinayaka Synthetics Limited generated 320.28M in revenue and converted that into 30.50M in net income, yielding earnings per share of 0.34. EBITDA reached 30.97M, while operating income came in at 30.97M.
| Revenue | 320.28M |
| Gross Profit | 166.71M |
| Operating Income | 30.97M |
| Pretax Income | 40.27M |
| Net Income | 30.50M |
| EBITDA | 30.97M |
| EBIT | 30.97M |
| Earnings Per Share (EPS) | 0.34 |
Swasti Vinayaka Synthetics Limited holds 2.17M in cash and equivalents against 42.51M in total debt, resulting in a net debt position of 40.66M. Total book value stands at 90.00M, with working capital of 235.03M providing operational flexibility.
| Cash & Cash Equivalents | 2.17M |
| Total Debt | 42.51M |
| Net Debt | 40.66M |
| Equity (Book Value) | 90.00M |
| Book Value Per Share | 1.00 |
| Working Capital | 235.03M |
Swasti Vinayaka Synthetics Limited operates with a gross margin of 52.05, reflecting its pricing power and cost economics. The operating margin of 9.67 and net profit margin of 9.52 provide insight into operational efficiency.
| Gross Margin | 52.05 |
| Operating Margin | 9.67 |
| Pretax Margin | 12.57 |
| Profit Margin | 9.52 |
| EBITDA Margin | 9.67 |
Swasti Vinayaka Synthetics Limited's most recent stock split took place on August 23, 2021 with a 7:9 split ratio.
| Last Split Date | 8/23/2021 |
| Split Ratio | 7:9 |
Swasti Vinayaka Synthetics Limited posts an Altman Z-Score of 2.83, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.83 |